Celia Owen is a Canadian actress making her mark in the acting world. The leading performer has already garnered praise and accolades for her performances, including the television series ...

How many Broadway shows has Celia Keenan-Bolger been in ... Best Performance by an Actress in a Featured Role in a Play (Tony Awards) for Mother Play, Outstanding Featured Actress in a Play ...

Some kids dream of becoming President of the United States or going into outer space. But Celia always dreamed of being a writer. That’s why she started her own lifestyle magazine in first grade.

A Robert Johnson biopic from Jesse Collins Entertainment and Concord Originals is in development, Deadline can reveal ...

Famed architect Frank Lloyd Wright, who designed the S.C. Johnson and Son Wax Co. headquarters in Racine, Wisconsin in 1936, ...

Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to report fourth-quarter earnings Wednesday morning, with analysts expecting sales and profits to grow year-over-year.

Bryan Johnson has dropped the medicine he had been taking for last five years. Bryan Johnson, the 47-year-old tech entrepreneur who has spent millions on his quest to reverse his biological age ...

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...

Supported by operational growth of 6.7%, Johnson & Johnson (JNJ, Financials) reported a 5.3% rise in fourth-quarter revenues to $22.5 billion. With operational growth of 5.9% except for COVID-19 ...

It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to focus on pharmaceuticals and medical technology. Johnson & Johnson has wasted no time expanding its ...

Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...